Serkan Akin

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Expression and prognostic value of cytotoxic T-lymphocyte-associated 4 protein in classic Hodgkin lymphoma.

Expression and prognostic value of cytotoxic T-lymphocyte-associated 4 protein in classic Hodgkin lymphoma.

Journal: Expert review of hematology

Published: May 25, 2026

Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

Dose-Adjusted EPOCH-R in Aggressive B-Cell Lymphomas: Efficacy, Molecular Prognostic Factors, and Real-World Outcomes from a Multicenter Turkish Cohort-A Turkish Oncology Group (TOG) Study.

Journal: Medicina (Kaunas, Lithuania)

Published: April 10, 2026

Cell therapy in sarcoma: current landscape and future directions.

Cell therapy in sarcoma: current landscape and future directions.

Journal: Journal for immunotherapy of cancer

Published: December 29, 2025

Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG).

Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG).

Journal: Journal of chemotherapy (Florence, Italy)

Published: September 11, 2025

PET in myeloma redefined: a comparative imaging study with FDG and fluorocholine PET/CT.

PET in myeloma redefined: a comparative imaging study with FDG and fluorocholine PET/CT.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 19, 2025

Impact of Time-to-Treatment Initiation and First Inter-Cycle Delay in Patients with Hodgkin Lymphoma.

Impact of Time-to-Treatment Initiation and First Inter-Cycle Delay in Patients with Hodgkin Lymphoma.

Journal: Journal of clinical medicine

Published: May 09, 2025

Evaluating Immunotherapy Responses in Neuro-Oncology for Glioblastoma and Brain Metastases: A Brief Review Featuring Three Cases.

Evaluating Immunotherapy Responses in Neuro-Oncology for Glioblastoma and Brain Metastases: A Brief Review Featuring Three Cases.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: February 15, 2025

Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.

Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: November 15, 2024

Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study.

Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study.

Journal: Cancer medicine

Published: September 04, 2024

The Role of Radiotherapy in Indolent Ocular Adnexal and Orbital Lymphomas.

The Role of Radiotherapy in Indolent Ocular Adnexal and Orbital Lymphomas.

Journal: Head & neck

Published: August 05, 2024

Immune checkpoint blockade and CAR T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma: Challenges and opportunities.

Immune checkpoint blockade and CAR T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma: Challenges and opportunities.

Journal: Heliyon

Published: July 30, 2024

Plasmacytoma and Amyloid Lymphadenopathy, FDG, and Fluorocholine.

Plasmacytoma and Amyloid Lymphadenopathy, FDG, and Fluorocholine.

Journal: Clinical nuclear medicine

Published: April 01, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026